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Background: Keratoconus (KC) is the most common primary ectatic disease of the cornea and a major indication
for corneal transplant. To date, limited KC-associated-risk loci have been identified. Association has recently been
suggested between KC and 8 single nucleotide polymorphisms (SNPs) in the genomic regions of FNDC3B, COL4A3,
MPDZ-NF1B, RXRA-COL5A1, LCN12-PTGDS, FOXO1, and BANP-ZNF469. These SNPs are associated with central corneal
thickness (CCT), a known risk factor to KC. We are questioning whether these SNPs are significantly associated with
KC in a Saudi Arabian population. The study included 108 unrelated KC cases and 300 controls. Patients were
diagnosed with KC according to the Schimpff-flow based elevation map of the cornea. DNA genotyping was done
using probe-based allelic discrimination TaqMan assays. Allele frequencies were compared between the cases and
controls.
Results: All SNPs were successfully genotyped with high efficiency (>95 %). The SNPs had no significant deviation
in cases or controls from Hardy-Weinberg Equilibrium (HWE, p value > 0.05). None of the selected SNPs were
significantly associated with KC in the Saudi Arabian population. However, we replicated the same trend of minor
allele frequency (MAF) between cases and controls reported by a recent GWAS regarding the 5 SNPs rs4894535
(FNDC3B, chr3: 171995605), rs1536482 (RXRA-COL5A1, chr9: 137440528), rs7044529 (COL5A1, chr9: 137568051),
rs11145951 (LCN12-PTGDS, chr9: 139860264), and rs2721051 (FOXO1, chr13: 41110884).
Conclusions: This is the first study investigating the association of these SNPs with KC in a population from Saudi
Arabia. We replicated the same trend of MAF alteration of the association between the SNPs rs4894535 (FNDC3B, chr3:
171995605), rs7044529 (COL5A1, chr9: 137568051), rs11145951 (LCN12-PTGDS, chr9: 139860264) and rs2721051 (FOXO1,
chr13: 41110884) and KC-risk as reported by a recently published GWAS. Consistently replicated population-based
studies are necessary to identify and/or confirm genetic susceptibility for certain diseases. We acknowledge that the lack
of significance in our study is due to our small sample size and insufficient statistical power; however our data
still add to the body of evidence of potential KC-candidate SNPs. This report aims at supporting the possible
association between CCT-associated SNPs and KC susceptibility.* Correspondence: yutliu@gru.edu
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Keratoconus (KC) is the most common primary non-
inflammatory ectatic disease of the cornea. It is one of
the major indications for corneal transplant in the devel-
oped countries [1, 2]. KC usually develops during pu-
berty or during the second decade of life. In most cases
it progresses asymptomatically and both eyes are af-
fected. The progression of the disease typically continues
until the fourth decade of life before it eventually stabi-
lizes [3]. The clinical signs of the keratoconus are highly
variable depending on the stage of disease progression.
Cases may present with any one or a combination of
these different signs. Vogt’s striae can be observed by
slit-lamp examination of the cornea. These striae appear
as fine vertical lines in the deep stroma and Descemet’s
membrane. They disappear transiently on gentle pres-
sure. Munson’s sign is another useful feature for the
diagnosis of keratoconus. This sign is observed as a v-
shaped conformation of the lower lid when the eyelid is
in a downgaze position. Munson’s sign develops as a re-
sult of corneal ectasia [2–4]. As the disease severely pro-
gresses, acute stromal edema occurs causing breaks in
the Descemet’s membrane. These breaks in the mem-
brane lead to aqueous leakage causing a phenomenon
known as “hydrops” [5]. This stromal edema and breaks
of the Descemet’s membrane further progress to corneal
scarring. Despite the well-established clinical picture of
keratoconus along with the extensive research on its eti-
ology, the exact cause and pathogenesis remain largely
unknown [2, 3, 6].
Increasing evidences suggest the involvement of a gen-
etic component in disease susceptibility. This hypothesis
is getting widely accepted especially with the predomin-
ance of KC among certain families, twins and particular
ethnicities [7–9]. Accordingly, family history is an im-
portant risk factor and obtaining a thorough family med-
ical history is crucial when considering a refractive
surgery [8, 10]. Various candidate single nucleotide poly-
morphisms (SNPs) and copy number variations (CNV)
have been associated with the susceptibility of KC [2, 6,
11–17]. In 2011, Rosenfeld et al. [18] reported copy
number change (deletion) of 5q31 in KC patients. This
group has reported the aforementioned CNV in a family
with autosomal dominant KC as well as in patients with
KC associated with other ocular and developmental ab-
normalities. The interest in CNV was not limited to the
analysis of developmental pathway genes as in the case
with deletions within 5q31. Recently, with the ongoing
studies exploring the potential role of ROS in the patho-
genesis of KC [19–21], a possible association between
mtDNA (mitochondrial DNA) CNV and KC has also
gained interest, yet still debatable. In 2015, Hao et al.
[22] reported a significant decrease in mtDNA copy
number in KC patients versus controls in Han Chinesepopulation. This study further highlights the possible in-
volvement of CNV in KC-susceptibility. Moreover,
mtDNA may be an interesting candidate for further
studies if we consider its direct contribution to mito-
chondrial functions and hence possible effects on the
generation of reactive oxygen species (ROS). ROS is a
known contributor to tissue damage and can be a sig-
nificant player in the characteristic corneal thinning and
ectasia that lead to the development and progression of
KC [19].
Despite the available evidences and the extensive gen-
etic research in KC over the past decades, the associ-
ation of these loci with KC is still controversial and none
of these genetic loci has been definitely confirmed as a
KC-associated genetic factor [2, 11, 23–27]. Among the
various reported KC-associated candidate genes are
VSX1 (Visual System Homeobox 1), MIR184 (microRNA
184) and DOCK9 (Dedicator of Cytokinesis 9), in
addition to other candidate single nucleotide polymor-
phisms (SNPs) in various other genetic loci that need
further investigations [13, 14, 16, 28]. On the contrary,
many follow-up reports did not identify any mutations
within these candidate genes in KC patients among the
specific study populations [29, 30]. These contradictory
data suggest the genetic heterogeneity of the disease. Ac-
cordingly, further extensive genetic analyses and wider
genomic screening are necessary to identify the underlying
genetic causation of the disease and to help understanding
its uncertain pathogenesis.
Genome-wide association studies (GWAS) have become
a powerful tool to investigate the genetic etiology of com-
plex diseases [23]. Several GWAS have been performed to
study KC in different populations. A study by Li and col-
leagues [24] detected no significant genome-wide associa-
tions in Caucasian KC patients. However, the most
significant association was detected with variants near the
RAB3GAP1 gene whose mutation is also associated with
other ocular abnormalities [31, 32]. Likewise, another re-
port have suggested a possible association between KC
and a variant related to HGF (hepatocyte growth factor)
in an Australian population [33, 34]. Interestingly, the
HGF gene has been previously reported in association
with refractive error in Han Chinese and Caucasian
populations [35, 36].
Corneal thinning is a known pathophysiological feature
in KC and central corneal thinning has been previously re-
ported as a major risk factor for KC [37, 38]. Recently, a
meta-analysis including more than 20,000 European and
Asian individuals investigated the association between
central corneal thickness (CCT)-associated genetic vari-
ants and KC [15]. Of the 16 identified CCT-associated
loci, only 2 loci conferred a significant association with
KC. These loci were close to the FOXO1 (forkhead box
O1) and FNDC3B (fibronectin type III domain containing
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tween these 2 SNP variants and KC in an Australian
population [39], but failed to replicate the reported associ-
ation. However, they reported the same trend of minor al-
lele frequency and odds ratio (OR) as the aforementioned
report by Lu et al. [15]. Given the prerequisite of replica-
tive studies to confirm the genetic associations of KC in
different populations, we selected to investigate eight
SNPs that have been previously reported in the GWAS by
Lu et al. [15]. In this study, we attempt to investigate the
association of these CCT-associated SNPs and KC in a
population from Saudi Arabia.
Results
Our study included 108 isolated KC cases and 300 con-
trols matched for ethnicity. The average age for all KC
subjects was 28.3 ± 6.9 years and 53.7 % of our cases were
females. As shown in Table 1, the clinical examination re-
vealed the presence of Munson’s sign in at least one eye of
43.3 % of the KC patients. Vogt’s striae was observed at
least in one eye of 50.7 % of the KC patients. Corneal
hydrops was noticed in at least one eye of 67.2 % of the
KC patients while scaring was only detected in 29.9 % KC
patients with at least one eye affected (Table 1). Average
keratometry in KC patients was 51.1 ± 8.1D for the right
eye and 53.2 ± 9.3D for the left eye. The average central
corneal thickness in KC patients was 429.8 ± 82.3 μm for
the right eye and 411.5 ± 86.8 μm for the left eye. Blood
samples were collected from all subjects for DNA isolation
and genotyping.
We selected the eight studied SNPs (Table 2) based on
the study by Lu et al. [15]. These SNPs are located within
or near the genomic regions of the following genes:
FNDC3B, COL4A3 (collagen type IV alpha 3), MPDZ
(multiple PDZ domain protein)-NF1B (neurofibromin 1b),Table 1 Clinical phenotype of keratoconus patients
Mean age (years) 28.3 ± 6.9
% Female 53.7 %
% Munson Sign OD 35.8 %
OS 43.3 %
% Vogts Striae OD 41.8 %
OS 50.7 %
% Hydrops OD 58.2 %
OS 67.2 %
% Scarring OD 20.9 %
OS 29.9 %
Average Keratometry (In diopter) OD 51.1 ± 8.1
OS 53.2 ± 9.3
Central Cornea Thickness (μm) OD 429.8 ± 82.3
OS 411.5 ± 86.8
OD right eye; OS left eyeRXRA (retinoid X receptor alpha) - COL5A1 (collagen type
V alpha 1), LCN12 (lipocalin 12) – PTGDS (prostaglandin
D2 synthase 21 kDa), FOXO1 (Forkhead box protein O1),
and BANP (BTG3 associated nuclear protein) -ZNF469
(zinc finger protein 469). The selected SNPs are also
associated with central corneal thickness (CCT), a
known risk factor to KC. Genotyping call rate for
rs9938149 (BANP-ZNF49, chr16:88331640), rs7606754
(COL4A3, chr2:228135180), and rs4894535 (FNDC3B,
chr3:171995605) was 97.5 %, for rs7044529 (COL5A1,
chr9:137568051) was 98.7, for rs2721051 (FOXO1, chr13:
41110884) was 99.1 %, for rs1536482 (RXRA-COL5A1,
chr9:137440528) was 95.7, for rs1324183 (MPDZ-NF1B,
chr9:13557491) was 97.3, and for rs11145951 (LCN12-
PTGDS, chr9:139860264), was 99.5. The minor allele
frequency (MAF) was calculated and compared in cases
versus controls using 2x2 contingency tables. The sig-
nificance level (p value) was calculated and odds ratio
(OR) for each SNP was determined at a 95 % confi-
dence interval (CI). The MAF, OR and p values for all
the investigated SNPs in cases versus controls is sum-
marized in Table 3.
Our data did not show any statistically significant associ-
ation of the eight previously reported SNPs with KC in the
Saudi Arabian population. However, in comparison to the
GWAS by Lu et al. [15], we did notice a similar trend/mag-
nitude of allele frequency alterations between cases and
controls for 5 of the 8 investigated SNPs (Table 4),
including rs4894535 (FNDC3B, chr3:171995605), rs13241
83 (MPDZ-NF1B, chr9:13557491), rs1536482 (RXRA-
COL5A1, chr9:137440528), rs2721051 (FOXO1, chr13:
41110884) and rs9938149 (BANP-ZNF49, chr16:88331640).
Based on the Quanto calculation, our dataset had a rela-
tively low statistical power to detect significant associations,
ranging from 20–64 %. We noticed that SNPs rs4894535
(FNDC3B, chr3:171995605) and rs2721051 (FOXO1,
chr13:41110884) yielded the highest statistical power of
50 % and 64 % respectively for a positive association.
Discussion
This is the first report suggesting an association between
CCT-associated SNPs and KC in a population from Saudi
Arabia. Population-based replicative studies are necessary
to identify and/or confirm genetic susceptibility for certain
diseases. We present a cohort of homogenous ethnic back-
ground and well-defined clinical phenotype in an attempt
to confirm the genetic association reported by a recent
CCT GWAS by Lu et al. [15]. Their study was conducted
among individuals with European and Asian ancestries
and identified significant associations between KC and
CCT in a meta-analysis of more than 20,000 individuals
including KC-affected and non-affected individuals. They
further examined the association between these CCT loci
and KC risk in two independent studies that include
Table 2 Summary of the screened SNPs, assays ID and probe sequences utilized in the study
dbSNP Gene symbol NCBI assembly locationa Assay ID Context sequence [VIC/FAM]
rs7606754 COL4A3 chr2: 228135180 C__381076_10 AAATATACTTAGATCAAACTATTCA[A/G]AGAGGCTTGTTAAAATTTACCAATA
rs4894535 FNDC3B chr3: 171995605 C__11808243_30 TTTTTTCCATTTTCCATAGTCCTTA[C/T]CCTTCCCTTTTGTTTTATATACCCA
rs1324183 MPDZ-NF1B chr9: 13557491 C___7609107_10 GGTTTGTTTTTCACCCTATTCCTCC[A/C]ACTTCCTTCAAGGCCCCTTAGAACT
rs1536482 RXRA-COL5A1 chr9: 137440528 C___9201021_10 TAGGCTCCAACATGTAAATGCTGGG[A/G]GGACGCACACGTTCAAACCATAGCA
rs7044529 COL5A1 chr9: 137568051 C__29292365_20 TTTCCAGAAGTAACCCCTCAACTCT[C/T]TGATCGGTATTGTTCTGGACTTACT
rs11145951 LCN12-PTGDS chr9: 139860264 C__31552589_20 AAGCTGCCAGTAGCTGCAGCTGGCC[C/T]GATGTGAGCCACAAAACCGGATGTG
rs2721051 FOXO1 chr13: 41110884 C__11302573_10 GAGCCAAATATCCTGCCAGCCAGCA[C/T]GGACCTGCTCCCAAGAATCATGTGT
rs9938149 BANP-ZNF49 chr16: 88331640 C__29917063_20 CTGCAATTGTCCCACAGGTCTTGTC[A/C]CCAGAAATCAAGTCCTTCTTCATCT
SNP single nucleotide polymorphism; COL4A3 Collagen, type IV, alpha (Goodpasture antigen); FNDC3B fibronectin type III domain containing 3B; MPDZ multiple
PDZ domain protein; NF1B neurofibromin 1b; COL5A1 collagen, type V, alpha 1; LCN12 lipocalin 12; PTGDS prostaglandin D2 synthase 21 kDa; FOXO1 forkhead box
O1; BANP BTG3 associated nuclear protein; ZNF469 zinc finger protein 469
aThe chromosomal location is based on UCSC GRCh37/hg19; chr, chromosome; Assays are supplied by Life technologies (Carlsbad, CA, USA)
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European American). Among CCT-associated SNPs, this
group reported an association between KC and five CCT-
associated SNPs. In the aforementioned report only two of
the five reported SNPs; rs2721051 (FOXO1, chr13:411108
84) and rs4894535 (FNDC3B, chr3:171995605), actually
achieved statistical significance in association with KC
with p-values of 3.2E-06 and 1.3E-06 respectively and
with an OR of 1.5 for both SNPs. Although, our study
was unable to detect a statistically significant associ-
ation between the reported SNPs and KC, our data
were still consistent in the effect direction as compared
to the study by Lu et al. [15].
Furthermore, similar to the aforementioned GWAS, we
consistently replicated the same minor alleles in cases and
controls for all SNPs and the same trend of OR and MAF
alterations in five of the eight suggested KC-associated al-
leles. Moreover, comparing our results to those reported
by Lu et al. [15], both studies reported almost the same
minor allele frequency for 4 of the reported eight alleles
namely, rs4894535 (FNDC3B, chr3:171995605), rs1324183
(MPDZ-NF1B, chr9:13557491), rs2721051 (FOXO1, chrTable 3 Association between CCT-associated SNPs and KC risk in th
Locus Lead SNP A1/A2 MA M
COL4A3 rs7606754 A/G A 0
FNDC3B rs4894535 C/T T 0
MPDZ-NF1B rs1324183 A/C A 0
RXRA-COL5A1 rs1536482 A/G A 0
COL5A1 rs7044529 C/T T 0
LCN12-PTGDS rs11145951 C/T T 0
FOXO1 rs2721051 C/T T 0
BANP-ZNF49 rs9938149 A/C C 0
CCT Central cornea thickness; SNP single nucleotide polymorphism; KC keratoconus
derived from two-tailed fisher exact test; OR odds ratio; CI confidence interval. COL4
domain containing 3B; MPDZ multiple PDZ domain protein; NF1B neurofibromin 1b
synthase 21 kDa; FOXO1 forkhead box O1; BANP BTG3 associated nuclear protein; Z13:41110884) and rs9938149 (BANP-ZNF49, chr16:883316
40) whereas the remaining four SNPs share the same
trend of MAF although the frequency does not exactly
match (Table 4). As for the OR, our data show that
SNP rs4894535 (FNDC3B, chr3:171995605) and
rs2721051 (FOXO1, chr13:41110884), has an OR of 1.4,
which is close to the OR of these SNPs from Lu et al.
[15] (OR, 1.5). These SNPs are also interestingly the
ones that achieved significant association with KC risk
in the GWAS by the same group [15].
Accordingly, our study has achieved the same trend of
KC-association of the SNPs reported by Lu et al.; how-
ever, our small sample size (108 cases and 300 controls)
is probably the main reason behind the lack of signifi-
cance and the limited statistical power (20 %–64 %) of
our dataset. Despite these facts, there is still a clear over-
lap between our data set and that of Lu et al. especially
with the SNPs achieving most significance in their study
which are rs4894535 (FNDC3B, chr3:171995605) and
rs2721051 (FOXO1, chr13:41110884).
In the same context, Sahebjada and colleagues [39] have
also attempted to study the association between KC ande Saudi Arabian study population
AF Case MAF Control p-value OR (95 % CI)
.35 0.37 0.6 0.9 (0.7-1.3)
.16 0.12 0.1 1.4 (0.9-2,2)
.25 0.28 0.4 0.8 (0.8-1.2)
.45 0.41 0.4 1.1 (0.8-1.6)
.14 0.13 0.8 1.1 (0.7-1.7)
.44 0.49 0.2 0.8 (0.6-1.1)
.14 0.11 0.2 1.4 (0.9-2.2)
.29 0.32 0.4 0.9 (0.6-1.2)
; A1/A2 Allele 1/Allele 2; MA minor allele; MAF minor allele frequency; p-value,
A3 Collagen, type IV, alpha (Goodpasture antigen); FNDC3B fibronectin type III
; COL5A1 collagen, type V, alpha 1; LCN12 lipocalin 12; PTGDS prostaglandin D2
NF469 zinc finger protein 469
Table 4 Comparison between MAF in our data set and the data set from Lu et al. 2013 [15] Nat Genetics
SNP and MA Data from the this study Data from Lu et al. 2013 [15]
(108 cases/300 controls) (652 cases/2,761 controls)
Lead SNP Allele MAF (cases) MAF (controls) OR MAF (cases) MAF (controls) OR p-value
rs7606754 A 0.34 0.37 0.9 0.37 0.33 1.2 6.0E-03
rs4894535a T 0.16 0.12 1.4 0.21 0.16 1.5 1.3E-06
rs1324183 A 0.25 0.28 0.9 0.24 0.2 1.3 8.8E-05
rs1536482 A 0.45 0.41 1.1 0.4 0.34 1.3 1.2E-03
rs7044529a T 0.14 0.13 1.1 0.18 0.14 1.3 3.0E-04
rs11145951a T 0.44 0.49 0.82 0.45 0.49 0.89 0.03
rs2721051a T 0.14 0.11 1.4 0.14 0.1 1.5 3.2E-06
rs9938149 C 0.29 0.32 0.9 0.32 0.36 1.2 7.1E-03
SNP single nucleotide polymorphism; MA minor allele; MAF minor allele frequency; OR odds ratio
a These SNPs had similar trends of allele frequency changes between cases and controls as those reported by Lu et al. [15]
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rs1324183 (MPDZ-NF1B, chr9:13557491), rs1536482
(RXRA-COL5A1, chr9:137440528), rs2721051 (FOXO1,
chr13:41110884), rs7044529 (COL5A1, chr9:137568051)
and rs9938149 (BANP-ZNF49, chr16:88331640). Similarly,
with a sample size of 157 KC cases and 673 controls, their
dataset was not able to achieve statistical significance in
association with KC at any of these SNPs. Similar to ours,
their data failed to detect an association between SNPs
rs1536483 and rs7044529 and KC risk with OR = 1.1. Our
study was unable to replicate the suggested association by
Sahebjada et al. [39] between SNPs rs1324183 (MPDZ-
NF1B, chr9:13557491) (OR = 1.68) and rs9938149 (BANP-
ZNF49, chr16:88331640) (OR = 1.47) with KC. Despite the
non-significant results in both studies, our data and the
study by Sahebjada et al. [39] indicated the consistent
trend of MAF changes that Lu and colleagues [15] have
reported.
Interestingly, a recent publication by Hao et al. [40]
also aimed at replicating the association between KC
and six of the SNPs we assessed. Similar to ours, their
report studied SNPs rs4894535 (FNDC3B), rs1324183
(MPDZ-NF1B), rs1536482 (RXRA-COL5A1), rs7044529
(COL5A1), rs2721051 (FOXO1) and rs9938149 (BANP-
ZNF49). Hao and coworkers [40] successfully reported a
significant association with rs1324183 (MPDZ-NF1B) in
a cohort of 210 sporadic KC patients from a Han Chin-
ese population. The MAF and OR reported by their
group was 0.288 and 3.1 respectively. Compared to the
previous reports for the SNP rs1324183 (MPDZ-NF1B),
Lu et al. reported a MAF and OR of 0.24 and 1.33 re-
spectively, and Sahebjada et al. reported a MAF and OR
of 0.29 and 1.68 respectively. Consistently, our study re-
ported a MAF of 0.25, however the OR for this SNP in
our cohort was in the range of 0.8-1.2 probably due to
our sample size which is small compared to all the
above-mentioned studies. Furthermore, the inconsist-
ency regarding the OR and significance level across thefour studies is mainly due to the wide variation in the
sample size: the study by Lu et al. [15] was conducted
with 652 cases and 2,761 controls, that of Sahebjada
et al. [39] with 157 cases and 673 controls, that of Hao
et al. [40] with 210 cases and 191 controls, and our
study with 108 cases and 300 controls. However, the
similar MAF and OR trend confers that the SNP
rs1324183 (MPDZ-NF1B) may be associated with KC in
a small percentage of KC cases and its contribution may
vary among populations. Taken together, our data as well
as others’ suggest following up on these CCT-associated
SNPs and KC by additional replicative large scale studies
within different populations.
In contrast, the other SNP that was reported by Hao
et al. [40] with a borderline significance in the Han
Chinese population (rs295654; LOX) was not examined
by any of the other three reports. Nevertheless, LOX
gene has been previously reported as a candidate gene
for KC [41], thus although we are not able to contrast
their results to the findings by other groups, we believe
that further population-based follow-up studies regard-
ing this SNP may reveal a relevant genetic association.
Conclusions
In summary, we replicated the same trend of MAF alter-
ation and the suggested association between the SNPs
rs4894535 (FNDC3B, chr3: 171995605), rs7044529 (COL5
A1, chr9: 137568051), rs11145951 (LCN12-PTGDS, chr9:
139860264) and rs2721051 (FOXO1, chr13: 41110884)
and KC-risk as reported in the GWAS by Lu et al., the
Australian study cohort by Sahebjada et al. [39] as well as
the most recent Han Chinese study by Hao et al. [40]. We
understand that the small sample size of our data set is a
major weakness in this study, however we sought to report
the consistency of our results in supporting previously
published population-based studies. Our future plan is to
recruit more KC cases from the Saudi Arabian population
in an attempt to increase the statistical power of our study
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our replicative genetic study still supplements the body of
evidence available through population-based GWAS.
Methods
Study population
This case–control study adheres to the tenets of the
Declaration of Helsinki and was approved by the College
of Medicine ethical committee at King Saud University
(Riyadh, Saudi Arabia). All participants signed an in-
formed consent. Study subjects were self-identified as
Saudi Arabians furthermore; their ethnicity was con-
firmed through database of Arab families of Saudi Ara-
bian origin. Male and female patients (n = 108) were
recruited from the anterior segment clinic at King Abdu-
laziz University after examination. Cases and controls
were selected according to the inclusion and exclusion cri-
teria described previously [11, 42, 43]. In brief, KC cases
are diagnosed with the Schimpff-flow based examination
and are included in the study if the Schimpff-flow–based
elevation map showed posterior corneal elevation within
the central 5 mm ≥ +20 μm, inferior-superior dioptric
asymmetry (I-S value) > 1.2 diopters (D), and the steepest
keratometry > 47D. Cases were thoroughly examined for
the presence of keratoconus common clinical features in-
cluding Munson’s sign, Vogt’s striae, hydrops and scaring.
Keratometry was also measured for both eyes and sum-
mary of the clinical phenotype for all cases is included in
Table 1. Thorough family history is obtained for each pa-
tient and only one member from each family is included
in the study. On the other hand, sporadic cases were iden-
tified after examining their immediate family members
and accordingly were confirmed as isolated cases of KC.
The control subjects (n = 300) were recruited from the
general ophthalmology clinic. Controls were selected if
slit-lamp exam showed clear cornea and Schimpff-flow–
based elevation map within the normal limit. Exclusion
criteria for KC cases included refusal to participate, post-
LASIK ectasia as well as secondary KC cases including
those secondary to trauma, surgery, Ehlers-Danlos syn-
drome, osteogenesis imperfecta, and pellucid marginal de-
generation, while exclusion criteria for control subjects
included detection of any ocular disease(s) or previous
ophthalmic surgeries.
DNA genotyping
DNA was isolated from peripheral blood samples as de-
scribed previously [42–44]. Briefly, DNA was extracted
from the buffy layer using the Illustra blood genomicPrep
Spin kit (GE Healthcare Life Sciences, Buckinghamshire,
UK). We selected to screen eight CCT-associated SNPs
based on a study by Lu et al. [15]. These SNPs included
rs7606754 (COL4A3, chr2:228135180), rs7044529 (COL5A
1, chr9:137568051), rs4894535 (FNDC3B, chr3:171995605),rs2721051 (FOXO1, chr13: 41110884), rs1536482 (RXRA-
COL5A1, chr9:137440528), rs1324183 (MPDZ-NF1B, chr9:
13557491), rs11145951 (LCN12-PTGDS, chr9:139860264),
and rs9938149 (BANP-ZNF49, chr16:88331640). The se-
lected SNPs are related to different genetic loci as shown in
Table 2. TaqMan assays from Life Technologies (Carlsbad,
CA, USA) were used and their sequences are shown in
Table 2. TaqMan allelic discrimination assays were
employed for genotyping these 8 SNPs by the use of
Assays-On-Demand products with the ViiA7 Realtime
PCR system with 384-well block according to the
standard protocols from the manufacturer (Life Tech-
nologies Carlsbad, CA, USA). All 8 SNPs were geno-
typed in 408 Saudi Arabian DNA samples. For quality
control (QC) purposes, two CEPH (the Centre d'Etude
du Polymorphisme Humain, Foundation Jean Dausset,
Paris, France) standards were included in each 96-well
plate, and samples from two individuals were dupli-
cated across all plates, with the laboratory technicians
masked to their identities. Analysis of genotypes re-
quired matching QC genotypes within and across plates
and achieving a genotyping efficiency of at least 95 %.Statistical analysis
Hardy-Weinberg equilibrium (HWE) test of all SNPs was
performed using Michael H. Court’s (2005–2008) online cal-
culator (https://www.google.com/webhp?sourceid=chrome-
instant&ion=1&espv=2&ie=UTF-8#q=Hardy-Weinberg+
equilibrium+Tufts+online+calculator). All statistical ana-
lyses were performed using JavaStat (http://statpages.org/
ctab2x2.html) with 2-by-2 contingency tables [45]. P-values
were calculated using two-tailed Fisher exact test and odds
ratio (OR) was derived with 95 % confidence interval (CI)
using JavaStat [45]. Power calculations were performed
using Quanto software version 1.2.4 (University of Southern
California, Los Angeles, CA) using previously described
methods, assuming a population prevalence of 0.05 % and a
log-additive risk model [46, 47]. The power for each SNP
was calculated using the previously reported OR in Lu et al.
[15] and the allele frequency in our Saudi Arabia controls.
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